MLchartDataset catalogue

Eftilagimod alpha

Term · Oncology and biomedicine · MLC-T-ONC-013230

A T-cell immunostimulatory factor, derived from the soluble form of the lymphocyte-activation gene 3 (LAG-3) protein, with potential antineoplastic activity. Upon administration, alone or in combination with tumor antigens, eftilagimod alpha binds with high affinity to MHC class II molecules expressed by dendritic cells (DC), potentially resulting in DC maturation, DC migration to lymph nodes, enhanced DC cross-presentation of antigens to T cells, and antitumor cytotoxic T cell responses.

Table 1. Record
IdentifierMLC-T-ONC-013230
FieldOncology and biomedicine
SynonymsEfti; hLAG-31g; LAG-3-Ig-fusion protein; LAG-3Ig; sLAG-3-Ig
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013230",
  "term": "Eftilagimod alpha",
  "field": "Oncology and biomedicine",
  "definition": "A T-cell immunostimulatory factor, derived from the soluble form of the lymphocyte-activation gene 3 (LAG-3) protein, with potential antineoplastic activity. Upon administration, alone or in combination with tumor antigens, eftilagimod alpha binds with high affinity to MHC class II molecules expressed by dendritic cells (DC), potentially resulting in DC maturation, DC migration to lymph nodes, enhanced DC cross-presentation of antigens to T cells, and antitumor cytotoxic T cell responses.",
  "synonyms": [
    "Efti",
    "hLAG-31g",
    "LAG-3-Ig-fusion protein",
    "LAG-3Ig",
    "sLAG-3-Ig"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/eftilagimod-alpha/"
}

Record 6,412 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.